![Drayton Wise](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Drayton Wise
Directeur/Membre du Conseil chez
IRULYA THERAPEUTICS INC.
Profil
Mr. Drayton Wise is on the Board of Directors at IRulya Therapeutics, Inc. Mr. Wise was previously employed as a Chief Commercial Officer by Insmed, Inc. He received his MBA from Emory University.
Postes actifs de Drayton Wise
| Sociétés | Poste | Début |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Directeur/Membre du Conseil | 08/10/2026 |
Anciens postes connus de Drayton Wise
| Sociétés | Poste | Fin |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 16/04/2025 |
Formation de Drayton Wise
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
Emory University
 Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
